MedTrace Logo

Postoperative Intraperitoneal Pain Management Following Laparoscopic Cholecystectomy

NCT06281418 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-01-10

No results posted yet for this study

Summary

Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. No. study has investigated IP granisetron as an adjuvant to standard care for postoperative pain management in patients undergoing LC.

Conditions

  • Post Operative Pain

Interventions

DRUG

Granisetron 1 Mg/mL Intravenous Solution

2mL intraperitoneal adminstration of granisetron (1 mg/mL)

OTHER

Normal saline

2 ml IP normal saline (0.9% NaCl)

Sponsors & Collaborators

  • Future University in Egypt

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2024-12-04
Completion
2024-12-04

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06281418 on ClinicalTrials.gov